Andover, MA, United States of America

Dae-Shik Kim

USPTO Granted Patents = 15 

 

 

Average Co-Inventor Count = 4.9

ph-index = 5

Forward Citations = 50(Granted Patents)


Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):

Title: The Innovative Contributions of Dae-Shik Kim

Introduction

Dae-Shik Kim is a prominent inventor based in Andover, MA, known for his significant contributions to the field of cancer treatment and pharmaceutical synthesis. With a total of 15 patents to his name, Kim has made remarkable strides in developing methods that enhance the efficacy of cancer therapies.

Latest Patents

Among his latest patents, Kim has developed methods for the treatment of bladder cancer. These methods provide innovative approaches to combat this challenging disease. Additionally, he has worked on macrocyclization reactions and intermediates that are useful in the synthesis of analogs of halichondrin B. This invention outlines methods for synthesizing eribulin or its pharmaceutically acceptable salts through a macrocyclization strategy. The process involves subjecting a non-macrocyclic intermediate to various carbon-carbon bond-forming reactions, resulting in a macrocyclic intermediate that is crucial for further pharmaceutical development.

Career Highlights

Dae-Shik Kim is currently associated with Eisai R&D Management Co., Ltd., where he continues to push the boundaries of innovation in drug development. His work has not only advanced scientific understanding but has also contributed to the creation of effective treatments for patients.

Collaborations

Kim has collaborated with notable colleagues, including Hyeong-wook Choi and Francis Gerard Fang, to further enhance the impact of his research and inventions.

Conclusion

Dae-Shik Kim's innovative work in the field of cancer treatment and pharmaceutical synthesis exemplifies the vital role of inventors in advancing medical science. His contributions continue to pave the way for new therapeutic options and improved patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…